GNMK
GenMark Diagnostics, Inc
GNMK
GNMK
Delisted
GNMK was delisted on the 21st of April, 2021.
106 hedge funds and large institutions have $368M invested in GenMark Diagnostics, Inc in 2019 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 41 increasing their positions, 28 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $74K
Holders
106
Holding in Top 10
–
Calls
–
Puts
$74K
Top Buyers
| 1 | +$2.98M | |
| 2 | +$2.51M | |
| 3 | +$2.03M | |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$1.79M |
| 5 |
HighTower Advisors
Chicago,
Illinois
|
+$1.6M |
Top Sellers
| 1 | -$10.4M | |
| 2 | -$4.23M | |
| 3 | -$3.39M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$3.21M |
| 5 |
CC
Casdin Capital
New York
|
-$3.19M |